Charles Winter
Director Técnico/Científico/I+D en JANUX THERAPEUTICS, INC. .
Fortuna: 3 M $ al 31/05/2024
Cargos activos de Charles Winter
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| JANUX THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/01/2021 | - |
Historial de carrera de Charles Winter
Antiguos cargos conocidos de Charles Winter.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 01/08/2020 | 01/03/2021 |
| SYNTHORX, INC. | Corporate Officer/Principal | 01/01/2020 | 01/08/2020 |
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 01/11/2016 | 01/06/2018 |
| JHL BIOTECH, INC. | Director Técnico/Científico/I+D | 01/07/2015 | 01/08/2016 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/09/2011 | 01/06/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1994 | 01/09/2011 |
Formación de Charles Winter.
| University of Wisconsin | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Taiwán | 2 |
Operativa
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 8 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| JANUX THERAPEUTICS, INC. | Health Technology |
| ANAPTYSBIO, INC. | Health Technology |
| DENALI THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Charles Winter
- Experiencia
